Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04595071 · ClinicalTrials.gov registry record · NA
Functional Outcomes of Voice Recognition Prosthesis
A NA study, sponsored by Liberating Technologies.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT04595071: Completed NA study, sponsored by Liberating Technologies.
NCT04595071 is a NA study that has completed, run by Liberating Technologies. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04595071, a NA study, has completed, sponsored by Liberating Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the use of a voice activated prosthesis interface controller for functional outcomes as compared to standard prosthesis control.
Primary Outcome
A Test for Unilateral Upper Limb Amputees
Interventions
- DEVICE Voice Activated Prosthetic Interface (VAPI) Controller
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-11-13 |
| Est. Completion | 2020-06-30 |
| Phase | NA |
What the finished NCT04595071 record still lists
NCT04595071 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Voice Activated Prosthetic Interface (VAPI) Controller is the first listed.
NCT04595071 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04595071 about?
NCT04595071 is a clinical study titled "Functional Outcomes of Voice Recognition Prosthesis". The purpose of this study is to evaluate the use of a voice activated prosthesis interface controller for functional outcomes as compared to standard prosthesis control.
What is the current status of trial NCT04595071?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2019-11-13. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT04595071?
The interventions under investigation include: Voice Activated Prosthetic Interface (VAPI) Controller (DEVICE).
Who is sponsoring clinical trial NCT04595071?
This trial is sponsored by Liberating Technologies, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04595071's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI